Skip to main content
Print Save

Hydrocortisone / neomycin / polymyxin b otic Pregnancy and Breastfeeding Warnings

Medically reviewed by Drugs.com. Last updated on Nov 23, 2022.

Hydrocortisone / neomycin / polymyxin b otic is also known as: AK-Spore HC Otic Suspension, Antibiotic Ear, Casporyn HC, Cort-Biotic, Cortatrigen, Cortatrigen Modified, Cortisporin Otic, Cortomycin, Drotic, Masporin Otic, Oti-Sone, Otimar, Otocort Sterile Solution, Otocort Sterile Suspension, Pediotic, UAD Otic

Hydrocortisone / neomycin / polymyxin b otic Pregnancy Warnings

Animal studies have shown this drug to be teratogenic. There are no adequate and well-controlled studies in pregnant women.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Use is not recommended.

US FDA pregnancy category: C

See references

Hydrocortisone / neomycin / polymyxin b otic Breastfeeding Warnings

Use is not recommended.

Excreted into human milk: Hydrocortisone: Yes

Comments: The effects in the nursing infant are unknown.

See references

See also

References for pregnancy information

  1. "Product Information. Cortisporin Otic (hydrocortisone/neomycin/polymyxin B otic)." Monarch Pharmaceuticals Inc (2022):
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

References for breastfeeding information

  1. "Product Information. Cortisporin Otic (hydrocortisone/neomycin/polymyxin B otic)." Monarch Pharmaceuticals Inc (2022):
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer